Selective serotonin reuptake inhibitor
(Redirected from Post-SSRI sexual dysfunction)
Selective serotonin reuptake inhibitors (SSRIs) are a class of pharmacological agents primarily used in the treatment of depression, anxiety disorders, and several other psychological conditions.
SSRIs are among the most frequently prescribed antidepressants across the globe due to their efficacy and tolerability[1]. Widely used SSRIs include fluoxetine (Prozac), paroxetine (Paxil), citalopram (Celexa), and escitalopram (Lexapro).
Therapeutic Indications[edit | edit source]
SSRIs are utilized in the management of a variety of mental health disorders, including[1]:
- Major depressive disorder
- Various anxiety disorders such as obsessive-compulsive disorder (OCD), panic disorder, and generalized anxiety disorder (GAD)
- Post-traumatic stress disorder (PTSD)
- Eating disorders
- Certain types of chronic pain
Depression[edit | edit source]
In the treatment of severe depression, SSRIs are often the first-line pharmacological intervention. For patients with moderate depression that is unresponsive to psychotherapy, SSRIs can provide symptom relief[2]. The effectiveness of SSRIs in the treatment of mild, transient depression remains a topic of ongoing research and debate[2].
Anxiety Disorders[edit | edit source]
For individuals diagnosed with GAD, SSRIs have demonstrated effectiveness in reducing anxiety, thereby facilitating participation in therapeutic interventions such as cognitive behavioral therapy[3]. SSRIs are also considered a first-line treatment for severe OCD. While not curative, the use of SSRIs in conjunction with psychotherapy improves treatment outcomes[4][5].
PTSD[edit | edit source]
The United States Food and Drug Administration has granted approval for the use of fluoxetine (Prozac) and paroxetine (Paxil) in the treatment of PTSD. However, SSRIs are not considered a standalone cure for PTSD and are typically used in combination with psychotherapeutic interventions[6][7][8]. Notably, apart from Prozac and Paxil, most other SSRIs do not appear to significantly improve PTSD symptoms[9].
Side Effects and Precautions[edit | edit source]
Like all medications, SSRIs can have side effects. These may include, but are not limited to:
- Nausea
- Diarrhea
- Dry mouth
- Insomnia
- Drowsiness
- Dizziness
- Sweating
These side effects often improve over time or with a dosage adjustment. However, it's important for patients to report any side effects to their healthcare provider.
Discontinuation Syndrome[edit | edit source]
Abrupt discontinuation of SSRIs can lead to a withdrawal-like condition known as SSRI discontinuation syndrome. Symptoms can include flu-like symptoms, insomnia, nausea, imbalance, sensory disturbances, and hyperarousal. Gradual dose reduction is typically recommended to minimize these effects[10].
Interactions[edit | edit source]
SSRIs can interact with a variety of other medications, including other antidepressants, certain pain or headache medications, and the herbal supplement St. John's Wort. These interactions can increase the risk of Serotonin syndrome, a potentially life-threatening condition[11]. Always discuss any other medications you are taking with your healthcare provider.
- Some other medicines for depression and anxiety:
- Monoamine oxidase inhibitors (MAOIs)
- Tricyclic antidepressants
- Serotonin-norepinephrine reuptake inhibitors (SNRIs)
- Lithium
- Buspirone (Buspar)
- Mirtazapine (Remeron)
- Some pain medications
- Pethidine/meperidine (Demerol)
- Tramadol (Ultram)
- Other things
- Dextromethorphan, an over-the-counter cough medicine
- St. John's Wort, an herb that some people use to treat depression
- MDMA (Ecstasy), an illegal drug
Related pages[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1
- ↑ 2.0 2.1 "Depression in Adults: Recognition and Management". National Institute for Health and Care Excellence. RCPsych Publications. 2009.
- ↑
- ↑
- ↑ Busko, Marlene (February 28, 2008). "Review Finds SSRIs Modestly Effective in Short-Term Treatment of OCD". Medscape. Archived from the original on April 13, 2013. Retrieved February 26, 2016.
- ↑
- ↑
- ↑
- ↑
- ↑
- ↑
Selective serotonin reuptake inhibitor Resources | |
---|---|
|
The following are antidepressant subclasses and drugs
MAO Inhibitors Isocarboxazid, Phenelzine, Tranylcypromine
SNRIs Duloxetine, Levomilnacipran, Venlafaxine
SSRIs Citalopram, Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, Sertraline, Vilazodone, Vortioxetine
Tricyclics Amitriptyline, Amoxapine, Clomipramine, Desipramine, Doxepin, Imipramine, Nortriptyline, Protriptyline, Trimipramine
Miscellaneous Bupropion, Flibanserin, Mirtazapine, Nefazodone, Trazodone
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD